Use of glucometers in the care of patients with diabetes mellitus
Authors:
Dana Prídavková; Udovít Šutarík; Peter Galajda; Marián Mokáň
Authors‘ workplace:
I. Interná klinika JLF UK a UN Martin
Published in:
Forum Diab 2020; 9(2): 110-114
Category:
Overview
Identification of blood glucose is a key indicator of glycemic control. There are a number of biochemical processes to verify blood glucose levels, dominated by electrochemical analysis for its simplicity and quantitative significance. However, an invasive approach is needed to determine blood glucose, which, due to its discomfort and pain on injection, can discourage patients from regular self-monitoring. Partial improvement concerning the number of injections is provided by interstitial fluid glucose monitoring systems, whether it is flash glucose monitoring (FMG) or continuous glycemic monitoring (CGM). Also non-invasive methodologies for determining the concentration of glucose in body fluids keep pace with the development.
Keywords:
diabetes mellitus – flash monitoring – glucometer – glycated hemoglobin – glycemic selfmonitoring
Sources
Hirsch IB. Introduction: History of Glucose Monitoring. In: American Diabetes Association. Role of Continuous Glucose Monitoring in Diabetes Treatment. Arlington 2018. Dostupné z WWW: <https://www.ncbi.nlm.nih.gov/books/NBK538968/>. Dostupné z DOI: <http://dx.doi.org/10.2337/db20181–1>.
Testing your glucose: a look back through time. Dostupné z WWW: <https://freestylediabetes.co.uk/freestyle-thinking/post/a-look-back-through-time>.
Yamada S. Historical Achievements of Self-Monitoring of Blood Glucose Technology Development in Japan. J Diabetes Sci Technol 2011; 5(5): 1300–1306. Dostupné z DOI: <http://dx.doi.org/10.1177/193229681100500541>.
Lee H, Hong JH, Baik S et al. Enzyme‐Based Glucose Sensor: From Invasive to Wearable Device. Adv Healthcare Mater 2018; 7(8): 1701150. Dostupné z WWW: <https://doi.org/10.1002/adhm.201701150>.
American Diabetes Association. Diabetes Technology: Standards of Medical Care in Diabetes—2020. Diabetes Care 2020; 43(Suppl 1): S77-S88. Dostupné z DOI: <https://doi.org/10.2337/dc20-S007>.
Kim MH, Bae SK, Kim KS. Comparative analysis of reliability and validity of six glucometers according to hematocrit based on ISO guidelines. Int J Clin Exp Med 2018;11(2):764–774. Dostupné z WWW: <www.ijcem.com/>.
Ginsberg BH. Factors Affecting Blood Glucose Monitoring: Sources of Errors in Measurement. J Diabetes Sci Technol; 2009; 3(4): 903–913. Dostupné z DOI: <http://dx.doi.org/10.1177/193229680900300438>.
International Organization for Standardization. ISO 15197. 2013. In vitro diagnostic test systems-Requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva 2013.
Lundsgaard-Nielsen SM, Pors A, Banke SO et al. Critical-depth Raman spectroscopy enables home-use non-invasive glucose monitoring. PLoS ONE 2018; 13(5): e0197134. Dostupné z DOI: <https://doi.org/10.1371/journal.pone.0197134>.
Moström P, Ahlén E, Imberg H et al. Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in Sweden. BMJ Open Diabetes Res Care 2017; 5(1): e000342. Dostupné z DOI: < https://doi.org/10.1136/bmjdrc-2016–000342>.
Rossi M, Lusicano G, Ceriello A et al. Real-world us of selfmonitoring of blood glucose in people with type 2 diabetes – an urgent field to improvement. Acta Diab 2018; 55(10): 1059–1066. Dostupné z DOI: <http://dx.doi.org/10.1007/s00592–018–1186-z>.
Fabris C, Kovatchev B (eds). Glucose Monitoring Devices: Measuring Blood Glucose to Manage and Control Diabetes. Academic Press 2020. ISBN 978–0128167144.
Genteel. Dostupné z WWW: <https://www.mygenteel.com/pages/about?hv=hdvje>.
Limity kategorizovaných zdravotníckych pomôcok MZSR. Dostupné z WWW: <https://www.health.gov.sk/?zoznam-kategorizovanych-zdravotnickych-pomocok>.
Zoznam kategorizovaných zdravotníckych pomôcok MZSR. Dostupné z WWW: <https://www.health.gov.sk/Clanok?zkzp-202007>.
Accu Chek Active. Accu Chek Performa. Accu Chek Instant. Manuál na použitie. Dostupné z WWW: <https://www.accu-chek.sk/glukomery>.
Glukomer Contour plus. Dostupné z WWW: <http://www.diabetes.ascensia.sk/products/contour-plus/>.
Finetest premium. Dostupné z WWW: <https://www.conex-trade.sk/Glukomer_Finetest>.
FORA Diamond Prima DM10. Dostupné z WWW: <https://www.foracare.cz/diamond-prima>.
Free Style Optium Neo. Užívateľská príručka. Dostupné z WWW: <https://www.abbottdiabetescare.sk/documents/Glukomer-FreeStyle-Optium-Neo.pdf>.
Gluneo Lite. Dostupné z WWW: <https://www.conex-trade.sk/Glukomer_Gluneo_Lite/>.
One Touch Select Plus/Flex. Dostupné z WWW: <http://www.aimport.sk/sk/glukometer-onetouch-select-plus-flex>.
Rightest GM550. Dostupné z WWW: <https://www.bionime.com/GM550.html>.
TD-4235 Mini. TD-4116 Next. Dostupné z WWW: <https://lorex.sk/sk/glukomery>.
Wellion Calla Light. Wellion Leonardo glu/chol.Wellion Leonardo glu/ket. Wellion LunaDuo. Wellion Calla Dialog. Dostupné z WWW: <https://www.wellion.sk/sk/Produkty/glukometre>.
Berard LD, Siemens R, Woo C. Diabetes Canada Clinical Practice Guidelines Expert Committee. Monitoring glycemic control. Can J Diabetes 2018; 42(Suppl 1): S47–S53. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jcjd.2017.10.007>.
[Consensus Committee]. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: The American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007; 30(9): 2399–2400. Dostupné z DOI: <http://dx.doi.org/10.2337/dc07–9925>.
Sheppard P, Bending JJ, Huber JW. Pre- and post-prandial capillary glucose selfmonitoring achieves better glycaemic control than pre-prandial only monitoring. Pract Diab Int 2005;22(1):15–22. Dostupné z DOI: <http://dx.doi.org/https://doi.org/10.1002/pdi.733>.
Malanda UL, Welschen LM, Riphagen II et al. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev 2012;(1):CD005060. Dostupné z DOI: <http://dx.doi.org/10.1002/14651858.CD005060.pub3>.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Forum Diabetologicum
Most read in this issue
- Liečba inhibítormi SGLT2 u pacientov so srdcovým zlyhávaním: Čo priniesla štúdia DAPA-HF pre kardiovaskulárnu diabetológiu?
- Pathophysiological aspects of chronic heart failure
- Gliflozins and heart: Analyses of EMPRISE study
- Chronic heart failure: a minimum for diabetologist